Clinical Trial Update: Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of methylphenidate hydrochloride extended-release capsules in children aged 4 to under 6 with ADHD completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate HCl Extended-Release Capsules (methylphenidate hydrochloride extended-release)

Snippet

Sponsor: Rhodes Pharmaceuticals, L.P. | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2021-11-24